COVID-19 vaccine makers are shifting gears and planning for a smaller, more competitive booster shot market after delivering as many doses as fast as they could...
Thailand may start rolling out its first locally-developed COVID-19 vaccine that deploys the same technology used by Pfizer Inc. by the end of this year after...
Johnson & Johnson on Tuesday cut its full-year profit expectation and suspended sales forecast for its COVID-19 vaccine after having earlier predicted as much as $3.5...
Japan has cancelled the purchase of about 40 million Astrazeneca Plc COVID-19 vaccine doses it agreed to buy last year, a health ministry official said in...
Pfizer Inc has signed a $5.29 billion deal with the US government to deliver 10 million courses of its COVID-19 oral antiviral drug starting this year,...
A trial of Pfizer Inc’s experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89 percent the chances of...
Pfizer has started testing its potential COVID-19 treatment as a preventive medicine aimed at warding off the virus if a close contact gets it. The drugmaker...
Researchers from Israel told a panel of US vaccine experts weighing a potential COVID-19 booster dose from Pfizer Inc. and BioNTech SE on Friday that it’s...
Pfizer Inc and its German partner BioNTech SE have submitted to U.S. regulators the initial data from an early-stage trial toward seeking authorization of a booster...
The world needs the cooperation of the Chinese government to trace the origins of COVID-19 and prevent future pandemic threats, two leading U.S. disease experts said...
To fight the pandemic at home, the United States gave its own vaccine manufacturers priority access to American-made materials needed to make the shots. As a...